Seeing Is Believing
Healthcare - Sector
Idera Pharmaceuticals's activity chart (see below) currently has 9 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 507 days.
Most recent stock forecast was given by from WEDBUSH on 19-Mar-2021. First documented stock forecast 27-May-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$5
5 years 6 months 18 days ago
(19-Mar-2021)
2/2 (100%)
$-13.17 (-72.48%)
1016
Buy Since 24-Sep-2018
$34
$26.77 (370.26%)
$238
5 years 6 months 19 days ago
(19-Mar-2021)
0/2 (0%)
$0.37 (1.10%)
Buy Since 09-Sep-2015
$255
5 years 6 months 19 days ago
(19-Mar-2021)
1/2 (50%)
$99.6 (64.09%)
26
Hold Since 19-Mar-2021
$14
5 years 6 months 19 days ago
(19-Mar-2021)
1/1 (100%)
$-32.53 (-69.91%)
984
Buy Since 27-May-2014
$952
$944.77 (13067.36%)
$952
11 years 9 months 21 days ago
(17-Dec-2014)
0/3 (0%)
$423.49 (80.13%)
What is IDRA (Idera Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on IDRA (Idera Pharmaceuticals)?
Which analyst has the current lower performing score on IDRA (Idera Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on IDRA (Idera Pharmaceuticals)?
Which analyst is the currently most bullish on IDRA (Idera Pharmaceuticals)?
Which analyst is the currently most reserved on IDRA (Idera Pharmaceuticals)?